Eric Lefkofsky and Tempus Labs – In the Forefront of Revolutionizing Cancer Care

Eric Lefkofsky is an entrepreneur, and one of his successful ventures is Tempus Labs. Tempus Labs has developed a molecular and clinical library of digitized genomic and patient information designed to provide physicians with a searchable database of DNA and clinical data so they can individualize care for cancer patients. The data is available to physicians in real time so they can make data-driven decisions to benefit each patient.

Tempus Labs is a privately held company with more than 11,000 employees in 48 countries. The company is still growing thanks to an infusion of cash from investors. According to a recent Chicago Tribune article, Tempus Labs recently received more than $80 million in additional funding. New investors like Kinship Trust Co. and T. Rowe Price Associates have joined long-time supporters like New Enterprise Associates and Revolution Growth. This infusion of cash not only increased total investments in Tempus Labs to more than $210 million but it simultaneously boosted the valuation of Tempus Labs to more than $1 billion.

Startups with a valuation of more than $1 billion are rare, so rare in fact, it led Aileen Lee a venture capitalist, to dub such startups as “a unicorn.” More than 50 percent of startups fail within the first four years, so the success of Eric Lefkofsky and Tempus Labs make them unique. As a biotech firm, Tempus Labs has successfully merged healthcare and technology. In an article written by Lefkofsky, he stated, “Healthcare, as an industry, is ripe for technological disruption. The potential for positive impact, particularly in the area of cancer care is both enormous and imminent.”

Tempus Labs and Eric Lefkofsky are in the forefront of healthcare research by leading a group of scientists, researchers, and physicians to develop cutting-edge tools to individualize health care. The mission of Tempus Labs is “to enhance the quality of human lives.” The continued success of Eric Lefkofsky and Tempus Labs indicate they are living up to their mission. Through genomic sequencing and mapping, Tempus Labs is in the forefront of revolutionizing cancer care.

To know more visit @: www.tempus.com/about-us/

Famous Urologist Dr. David Samadi Generally Advises Surgery First for Prostate Cancer

Recently the 2012 Republication candidate for President, Mitt Romney, announced he had surgery last summer to treat prostate cancer. Dr. Thomas Ahrling operated on Romney at University of California Irvine Hospital, and Romney’s prognosis is now good. Political experts expect to run for United States senator of the state of Utah when Senator Orrin Hatch retires. He joins John Kerry and Colin Powell as famous politicians who have had surgery for it and are still alive, well and active. Dr. David Samadi wrote about Romney’s case in The Huffington Post to pass on his advice regarding their treatment options.

Prostate cancer is common in older men. It’s rare in men under 40. 60% of cases are found in men over 65, with 66 the average age of diagnosis. The American Cancer Society predicts 164,690 will learn of their diagnosis in 2018. According to Dr. David Samadi, surgery should be the man’s first choice for treatment, especially if the cancer has not metastasized, meaning it has not spread to other parts of the body, so it remains localized in the prostate.

The other treatment is radiation therapy. In that case, the radiologist exposes the cancer to radiation. However, although the radiation is highly targeted, surrounding parts of the man’s body are still exposed. This raises the risk the man later suffers secondary cancers, especially of the rectum and bladder.

Dr. David Samadi has seen the medical studies on the results of both treatments. Almost all men who have the surgery and the cancer has not spread, survive. Men who get treated by radiation are two times as likely to die from the disease as men who get treated with surgery. And they are one-and-a-half times as likely to pass away earlier than the patients who chose surgery over radiation first.

Dr. Samadi has lots of information on prostates, prostate cancer and urology on his website. He has a video of himself as a guest on a Fox News Housecall, discussing these same issues. On the show, he says surgery is the first line of treatment for any cancer. That’s partly because it allows the doctor to more accurately stage the cancer, or to know just how big the tumor is and whether or not it has spread. On that show, he also mentions CyberKnife, explaining that although it sounds like surgery, it is another form of radiation, not surgery. According to the doctor, radiation should be the backup plan for treating cancer if surgery cannot complete the job.

Read More: insider.foxnews.com/tag/dr-david-samadi

Greg Finch Life and Career

There are more surgeries happening today than at any time in history. The technology involved in these surgeries has really started to progress where it is easier than ever before. Over time, this is something that a lot of people are ready to work on. Greg Finch is a great person in this field because he has so much experience. He likes to work with clients on their lifestyle factors in order to keep their likelihood of surgery down. He has proven that he has the knowledge needed to get the job done.

Greg Finch

When he first started in medicine, the world of business was much different. Greg Finch wanted to start helping others in a variety of ways. He saw a great opportunity in the field of surgery, not only because of the new technology but because of how much he could help others. Over time, he has proven to truly care about the lives of people who he is working with. Not only that, but he is excited to work on plan for the future.

Surgeries

Some of the most common surgeries throughout the world can be changed greatly with new technology. For example, the knee surgery is perhaps the most common form of surgery today. There is new technology that involves a lower cost procedure that will help others get to a new level in life. Not only that, but many people are ready to start thinking about the long term trajectory of their business this way. If you want to change the way that medicine is done, this is one of the best ways to do that. Greg Finch has proven that there is opportunity in this area of business, and he is working as hard as he can to figure out what to do.